成人一生中白质高信号与阿尔茨海默病生物标志物的纵向关系
该研究联合分析了4项纵向研究中371名认知正常个体(基线年龄19.6至88.20岁)的白质高信号体积与阿尔茨海默病生物标志物及认知的纵向数据,发现白质高信号体积的纵向增加与PET淀粉样蛋白摄取增加、MRI海马体积和皮层厚度降低及认知下降相关,其加速变化的拐点位于基线年龄60.46岁。
要点
- 白质高信号体积纵向增加与PET淀粉样蛋白摄取增加、MRI海马体积和皮层厚度降低及认知下降相关。
- 白质高信号体积加速变化的基线年龄拐点为60.46岁(95%CI 56.43-64.49)。
- 老年参与者白质高信号体积年增加量83.12 mm³/年,是年轻参与者6.35 mm³/年的13倍以上(p<0.0001)。
核心结论
- 白质高信号体积的纵向增加在基线年龄约60.46岁开始加速,并与PET淀粉样蛋白摄取、MRI结构结局及认知的纵向变化相关。
研究设计与样本
- 联合分析4项衰老与阿尔茨海默病纵向研究中371名认知正常个体的白质高信号体积与既定阿尔茨海默病生物标志物及认知的纵向数据,基线年龄19.6至88.20岁。
- 采用两阶段算法识别基线年龄拐点,并通过双变量线性混合效应模型估计白质高信号体积与阿尔茨海默病生物标志物的纵向相关性。
主要发现
- 白质高信号体积的纵向增加与PET淀粉样蛋白摄取纵向增加、MRI海马体积和皮层厚度降低及认知下降相关。
- 白质高信号体积的基线年龄拐点为60.46岁(95%CI 56.43-64.49),老年参与者年增加83.12(SE=10.19)mm³/年,比年轻参与者的6.35(SE=5.63)mm³/年快13倍以上(p<0.0001)。
- 几乎所有阿尔茨海默病生物标志物在老年参与者中同样观察到加速变化率。
- 白质高信号体积与MRI、PET淀粉样蛋白生物标志物及认知的纵向相关性在年轻参与者中似乎数值上更强,但与老年参与者无显著差异。
- 携带APOE ε4等位基因未改变白质高信号与阿尔茨海默病生物标志物之间的纵向相关性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: White matter hyperintensities (WMH) correlate with Alzheimer disease (AD) biomarkers cross-sectionally and modulate AD pathogenesis. Longitudinal changes have been reported for AD biomarkers, including concentrations of CSF β-amyloid (Aβ) 42, Aβ40, total tau and phosphorylated tau181, standardized uptake value ratio from the molecular imaging of cerebral fibrillar Aβ with PET using [11C] Pittsburgh Compound-B, MRI-based hippocampal volume, and cortical thickness. Correlations between established AD biomarkers and the longitudinal change for WMH have not been fully evaluated, especially among cognitively normal individuals across the adult life span. METHODS: We jointly analyzed the longitudinal data of WMH volume and each of the established AD biomarkers and cognition from 371 cognitively normal individuals whose baseline age spanned from 19.6 to 88.20 years from 4 longitudinal studies of aging and AD. A 2-stage algorithm was applied to identify the inflection point of baseline age whereby older participants had an accelerated longitudinal change in WMH volume, in comparison with the younger participants. The longitudinal correlations between WMH volume and AD biomarkers were estimated from the bivariate linear mixed-effects models. RESULTS: A longitudinal increase in WMH volume was associated with a longitudinal increase in PET amyloid uptake and a decrease in MRI hippocampal volume, cortical thickness, and cognition. The inflection point of baseline age in WMH volume was identified at 60.46 (95% CI 56.43-64.49) years, with the annual increase for the older participants (83.12 [SE = 10.19] mm3 per year) more than 13 times faster (p < 0.0001) than that for the younger participants (6.35 [SE = 5.63] mm3 per year). Accelerated rates of change among the older participants were similarly observed in almost all the AD biomarkers. Longitudinal correlations of WMH volume with MRI, PET amyloid biomarkers, and cognition seemed to be numerically stronger for the younger participants, but not significantly different from those for the older participants. Carrying APOE ε4 alleles did not alter the longitudinal correlations between WMH and AD biomarkers. DISCUSSION: Longitudinal increases in WMH volume started to accelerate around a baseline age of 60.46 years and correlated with the longitudinal change in PET amyloid uptake, MRI structural outcomes, and cognition.
引用
- Luo J, Ma Y, Agboola FJ, et al. Longitudinal Relationships of White Matter Hyperintensities and Alzheimer Disease Biomarkers Across the Adult Life Span. Neurology. 2023. PMID: 37202169. doi:10.1212/WNL.0000000000207378
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。